Moody’s still thinks the credit ratings of the world’s big drug companies are likely to get worse in the coming months. But Moody’s does find a few good things to say about the industry. A sampling of findings from the company’s... 

Here’s an executive compensation tidbit for your afternoon reading, courtesy of Eli Lilly. Steven Paul, Lilly’s R&D chief, will receive a cash severance payment of $2 million in connection with his retirement next year, the company said... 

Bristol-Myers Squibb filed plans with the SEC this morning to split off its Mead Johnson baby-formula unit to concentrate on its core pharmaceuticals business. While other big drug makers are busy diversifying in an effort to reduce the risks at the... 

The American Heart Association’s big scientific meeting starts Sunday, and everybody’s buzzing about results that will be presented Monday from a comparison of Merck’s cholesterol drug Vytorin against Abbott’s Niaspan. There’s... 

For people in their late teens and early 20s, taking an antidepressant may actually increase the risk of suicidal thoughts and behaviors , at least during initial treatment. So it’s important that those patients are carefully monitored. Citing... 

Roche, Elan and Biogen are going to team up to study why some patients taking certain drugs develop a rare brain infection called PML . This sort of thing has happened a few times in the last few years, as companies collaborate to examine safety problems... 

More news today on the cutbacks at Pfizer following the merger with Wyeth. Pfizer just sent out the list of research sites it’ll be shrinking and, in some cases, closing. Here’s the key paragraph: The company will move a number of functions... 

There’s lot of action these days aimed at curbing the abuse of prescription drugs. The FDA is working on a plan to make it harder for people to get access to unauthorized prescription painkillers, pain specialists have come out with guidelines... 

Now you see it. Now you don’t. So it goes with Boston Scientific’s third-quarter profit as a result of a settlement agreement with the Justice Department that the company announced today. Boston Scientific agreed to pay $296 million because of faulty... 

Should companies be allowed to buy large quantities of medicine like Tamiflu to have on hand in case their employees develop the H1N1 flu virus? Not according to the law in South Korea, where it’s illegal for non-medical professionals to purchase...